Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 346461 - 346480 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (L01FB01) inotuzumab ozogamicin | Besponsa, proszek do sporządzania koncentratu roztworu do infuzji, 1 mg | 1 fiol. proszku, 1 mg , 1 fiol. 1 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PfizerEuropeMAEEIG |
| Poland | (L01FD01) trastuzumab | Trazimera, proszek do sporządzania koncentratu roztworu do infuzji, 150 mg | 1 fiol. proszku, 150 mg , 1 fiol. proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG |
| Poland | (L01FD01) trastuzumab | Trazimera, proszek do sporządzania koncentratu roztworu do infuzji, 420 mg | 1 fiol. proszku, 420 mg , 1 fiol. proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG |
| Poland | (L01FD03) trastuzumab emtansine | Kadcyla, proszek do sporządzania koncentratu roztworu do infuzji, 160 mg | 1 fiol. proszku, 160 mg , 1 fiol. proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH |
| Poland | (L01FE02) panitumumab | Vectibix, koncentrat do sporządzania roztworu do infuzji, 20 mg/ml | 5 ml, 20 mg/ml , 1 fiol. 5 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Poland | (L01FE02) panitumumab | Vectibix, koncentrat do sporządzania roztworu do infuzji, 20 mg/ml | 20 ml, 20 mg/ml , 1 fiol. 20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. |
| Poland | (L01FF04) avelumab | Bavencio, koncentrat do sporządzania roztworu do infuzji, 20 mg/ml | 1 fiol.po 10 ml, 20 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MerckEuropeB.V. |
| Poland | (L01FF05) atezolizumab | Tecentriq, roztwór do wstrzykiwań, 1875 mg | 1 fiol.a 15 ml, 1875 mg , 1 fiol. 15 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheRegistrationGmbH |
| Poland | (L01FF06) cemiplimab | Libtayo, koncentrat do sporządzania roztworu do infuzji, 350 mg | 1 fiol., 350 mg , 1 fiol. 7 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronIrelandDesignatedActivityCompany(DAC) |
| Poland | (L01FG01) bevacizumab | Abevmy, koncentrat do sporządzania roztworu do infuzji, 25 mg/ml | 1 fiol.a 16 ml, 25 mg/ml , 1 fiol. 16 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BiosimilarCollaborationsIrelandLtd |
| Poland | (L01FG02) ramucirumab | Cyramza, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml | 2 fiol.po 10 ml, 10 mg/ml , 2 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms | EliLillyNederlandB.V. |
| Poland | (L01FX04) ipilimumab | Yervoy, koncentrat do sporządzania roztworu do infuzji (jałowy koncentrat), 5 mg/ml | 1 fiol.po 10 ml, 5 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX04) ipilimumab | Yervoy, koncentrat do sporządzania roztworu do infuzji (jałowy koncentrat), 5 mg/ml | 1 fiol.po 40 ml, 5 mg/ml , 1 fiol. 40 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma;Carcinoma, Renal Cell;Carcinoma, Non-Small-Cell Lung;Mesothelioma, Malignant;Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX07) blinatumomab | Blincyto, proszek do sporządzania koncentratu roztworu do infuzji, 38,5 µg | 1 fiol.prosz. + 1 fiol.roztw.stabilizującego 10ml, 38,5 mcg , 1 fiol. 10 ml roztworu stabilizującego | Wholesale price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | AmgenEuropeB.V. |
| Poland | (L01FX08) elotuzumab | Empliciti, proszek do sporządzania koncentratu roztworu do infuzji, 300 mg | 1 fiol., 300 mg , 1 fiol. 300 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX08) elotuzumab | Empliciti, proszek do sporządzania koncentratu roztworu do infuzji, 400 mg | 1 fiol., 400 mg , 1 fiol. 400 mg proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FX13) enfortumab vedotin | Padcev, proszek do sporządzania koncentratu roztworu do infuzji, 20 mg | 1 fiol., 20 mg , 1 fiol. proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | AstellasPharmaEuropeB.V. |
| Poland | (L01FX13) enfortumab vedotin | Padcev, proszek do sporządzania koncentratu roztworu do infuzji, 30 mg | 1 fiol., 30 mg , 1 fiol. proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Urologic Neoplasms | AstellasPharmaEuropeB.V. |
| Poland | (L01FX17) sacituzumab govitecan | Trodelvy, proszek do sporządzania koncentratu roztworu do infuzji, 200 mg | 1 fiol. proszku, 200 mg , 1 fiol. 50 ml proszku | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Triple Negative Breast Neoplasms | GileadSciencesIrelandUC |
| Poland | (L01FX22) loncastuximab tesirine | Zynlonta, proszek do sporządzania koncentratu roztworu do infuzji, 10 mg | 1 fiol. 10 mg, 10 mg , 1 fiol. 10 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell | SwedishOrphanBiovitrumAB(publ) |
Pages
